1. Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer

   • Alessandra Modena
   • Roberto Iacovelli
   • Giampaolo Tortora

   Review Article 11 July 2016 Pages: 569 - 577

   

2. Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer

   • Hartmut Kristeleit
   • Marina Parton
   • Muireann Kelleher

   Review Article Open access 16 May 2016 Pages: 579 - 591

   

3. The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?

   • Marco Puzzoni
   • Nicola Silvestris
   • Mario Scartozzi

   Review Article 17 May 2016 Pages: 593 - 603

   

4. Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment

   • Hiroki Ishihara
   • Tsunenori Kondo
   • Kazunari Tanabe

   Original Research Article 29 March 2016 Pages: 605 - 617

   

5. Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial

   • Oscar Arrieta
   • Graciela Cruz-Rico
   • Horacio Astudillo-de la Vega

   Original Research Article 01 April 2016 Pages: 619 - 629

   

6. Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma

   • Anne von Mässenhausen
   • Mario Deng
   • Sven Perner

   Original Research Article 07 April 2016 Pages: 631 - 642

   

7. A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)

   • John D. Hainsworth
   • James A. Reeves
   • Edward R. Arrowsmith

   Original Research Article 07 May 2016 Pages: 643 - 653

   

8. Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines

   • Mahesh Hegde
   • Kempegowda Mantelingu
   • Sathees C. Raghavan

   Original Research Article 17 May 2016 Pages: 655 - 665

   

9. Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus

   • Marianne Pavel
   • Nicole Unger
   • Oliver Bechter

   Original Research Article 19 May 2016 Pages: 667 - 675

   

10. Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer

    • Srividya Vaidyanathan
    • Pulari U. Thangavelu
    • Pascal H. G. Duijf

    Short Communication 29 March 2016 Pages: 677 - 686

    

11. Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer

    • H. Pluchart
    • E. Jacquet
    • M. Mousseau

    Therapy in Practice 04 April 2016 Pages: 687 - 691

    

12. Ceritinib: a Review in ALK-Positive Advanced NSCLC

    • Emma D. Deeks

    Adis Drug Evaluation 03 October 2016 Pages: 693 - 700